{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T21:08:17Z","timestamp":1783804097297,"version":"3.55.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancerf\u00f6reningen i Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016290","name":"Insamlingsstiftelsen Cancer- och Allergifonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001725","name":"Royal Swedish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003514","name":"Kommunfullm\u00e4ktige, Stockholms Stad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006350","name":"Stiftelsen Clas Groschinskys Minnesfond","doi-asserted-by":"publisher","award":["M19376"],"award-info":[{"award-number":["M19376"]}],"id":[{"id":"10.13039\/501100006350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007508","name":"Stiftelsen Sigurd and Elsa Goljes Minne","doi-asserted-by":"publisher","award":["LA2019-0143, LA2020-0077"],"award-info":[{"award-number":["LA2019-0143, LA2020-0077"]}],"id":[{"id":"10.13039\/501100007508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006472","name":"Universitatea de Medicina \u0219i Farmacie Grigore T. Popa - Iasi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Human papillomavirus positive (HPV<jats:sup>+<\/jats:sup>) tonsillar and base of tongue squamous cell carcinoma (TSCC\/BOTSCC), the major subsites of oropharyngeal squamous cell carcinoma (OPSCC) have favorable outcome, but upon relapse, outcome is poor and new therapies needed. Since, phosphatidyl-inositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) and fibroblast-growth-factor-receptor-3 (FGFR3) mutations often occur in such tumors, here, we tested targeted therapy directed to such genes in TSCC\/BOTSCC cell lines. We also combined the two types of inhibitors with each other, and cisplatin or docetaxel that are used clinically.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The HPV<jats:sup>+<\/jats:sup> CU-OP-2, -3, -20, UPCI-SCC-154, and HPV<jats:sup>-<\/jats:sup> CU-OP-17 and UT-SCC-60A cell lines were first tested for common PIK3CA\/FGFR3 mutations by competitive-allele-specific TaqMan-PCR. They were then treated with the food and drug administration (FDA) approved drugs, alpelisib (BYL719) and erdafitinib (JNJ-42756493) alone and in combination with cisplatin or docetaxel. Viability, proliferation, apoptosis and cytotoxicity responses were thereafter followed by WST-1 assays and the IncuCyte S3 Live<jats:sup>\u00ae<\/jats:sup> Cell Analysis System.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HPV<jats:sup>+<\/jats:sup> CU-OP-2 had a pS249C-FGFR3, and like CU-OP-20, a pE545K-PIK3CA mutation, while no other lines had such mutations. Irrespectively, dose dependent responses to all PI3K\/FGFR inhibitors were obtained, and upon combining the inhibitors, positive effects were observed. Cisplatin and docetaxel also induced dose dependent responses, and upon combination with the inhibitors, both positive and neutral effects were found.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The data suggest that FDA approved drugs alpelisib and erdafitinib efficiently inhibit TSCC\/BOTSCC cell line growth, especially when combined irrespective of presence of corresponding mutations and should be further explored, for use upon recurrent disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.640490","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T06:44:13Z","timestamp":1620715453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations"],"prefix":"10.3389","volume":"11","author":[{"given":"Stefan","family":"Holzhauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zupancic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona G.","family":"Ursu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Bersani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"N\u00e4sman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania N.","family":"Kostopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dalianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25585","article-title":"Changes in Incidence and Prevalence of Human Papillomavirus in Tonsillar and Base of Tongue Cancer During 2000-2016 in the Stockholm Region and Sweden","volume":"41","author":"Haeggblom","year":"2019","journal-title":"Head Neck"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e31813e5fbb","article-title":"Rising Incidence of Oropharyngeal Cancer and the Role of Oncogenic Human Papilloma Virus","volume":"117","author":"Ernster","year":"2007","journal-title":"Laryngoscope"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29254","article-title":"A High and Increasing HPV Prevalence in Tonsillar Cancers in Eastern Denmark, 2000-2010: The Largest Registry-Based Study to Date","volume":"136","author":"Garnaes","year":"2015","journal-title":"Int J Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31315","article-title":"Epidemiologic Associations of HPV-positive Oropharyngeal Cancer and (Pre)Cancerous Cervical Lesions","volume":"143","author":"Rietbergen","year":"2018","journal-title":"Int J Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.12.019","article-title":"Epidemiology of HPV-associated Oropharyngeal Cancer","volume":"50","author":"Pytynia","year":"2014","journal-title":"Oral Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13010","article-title":"A Global Epidemic Increase of HPV Induced Tonsil and Tongue-Base Cancer \u2013 Potential Benefit From a Pan-Gender Use of HPV Vaccine","volume":"287","author":"N\u00e4sman","year":"2020","journal-title":"J Intern Med"},{"key":"B8","article-title":"Human Papillomavirus Accounts Both for Increased Incidence and Better Prognosis in Tonsillar Cancer","volume":"28","author":"Dahlstrand","year":"2008","journal-title":"Anticancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human Papillomavirus and Survival of Patients With Oropharyngeal Cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2007.08.005","article-title":"Human Papillomavirus is a Favourable Prognostic Factor in Tonsillar Cancer and its Oncogenic Role is Supported by the Expression of E6 and E7","volume":"1","author":"Lindquist","year":"2007","journal-title":"Mol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.03.007","article-title":"A Model Using Concomitant Markers for Predicting Outcome in Human Papillomavirus Positive Oropharyngeal Cancer","volume":"68","author":"Bersani","year":"2017","journal-title":"Oral Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11958","article-title":"Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma","volume":"37","author":"N\u00e4sman","year":"2017","journal-title":"Anticancer Res"},{"key":"B14","article-title":"Intense CD44 Expression is a Negative Prognostic Factor in Tonsillar and Base of Tongue Cancer","volume":"32","author":"Lindquist","year":"2012","journal-title":"Anticancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.90","article-title":"Absent\/Weak CD44 Intensity and Positive Human Papillomavirus (HPV) Status in Oropharyngeal Squamous Cell Carcinoma Indicates a Very High Survival","volume":"2","author":"N\u00e4sman","year":"2013","journal-title":"Cancer Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ijc.27635","article-title":"MHC Class I Expression in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma in Correlation to Clinical Outcome","volume":"132","author":"N\u00e4sman","year":"2013","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077025","article-title":"HLA Class I and II Expression in Oropharyngeal Squamous Cell Carcinoma in Relation to Tumor HPV Status and Clinical Outcome","volume":"8","author":"N\u00e4sman","year":"2013","journal-title":"PloS One"},{"key":"B18","article-title":"Hla-A*02 in Relation to Outcome in Human Papillomavirus Positive Tonsillar and Base of Tongue Cancer","volume":"34","author":"Tertipis","year":"2014","journal-title":"Anticancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095624","article-title":"Correlation of LMP10 Expression and Clinical Outcome in Human Papillomavirus (HPV) Positive and HPV-Negative Tonsillar and Base of Tongue Cancer","volume":"9","author":"Tertipis","year":"2014","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2014.11.002","article-title":"Reduced Expression of the Antigen Processing Machinery Components TAP2, LMP2, and LMP7 in Tonsillar and Base of Tongue Cancer and Implications for Clinical Outcome","volume":"8","author":"Tertipis","year":"2015","journal-title":"Transl Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.11.010","article-title":"Cancer Stem Cell Enrichment Marker CD98: A Prognostic Factor for Survival in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer","volume":"50","author":"Rietbergen","year":"2014","journal-title":"Eur J Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038711","article-title":"Tumor Infiltrating CD8+ and Foxp3+ Lymphocytes Correlate to Clinical Outcome and Human Papillomavirus (HPV) Status in Tonsillar Cancer","volume":"7","author":"N\u00e4sman","year":"2012","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.03.019","article-title":"CD8+ and CD4+ Tumour Infiltrating Lymphocytes in Relation to Human Papillomavirus Status and Clinical Outcome in Tonsillar and Base of Tongue Squamous Cell Carcinoma","volume":"49","author":"Nordfors","year":"2013","journal-title":"Eur J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.277","article-title":"Stromal Infiltration of CD8 T Cells is Associated With Improved Clinical Outcome in HPV-positive Oropharyngeal Squamous Carcinoma","volume":"113","author":"Oguejiofor","year":"2015","journal-title":"Br J Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14796","article-title":"Distinct Patterns of Infiltrating CD8+ T Cells in HPV+ and CD68 Macrophages in HPV- Oropharyngeal Squamous Cell Carcinomas are Associated With Better Clinical Outcome But PD-L1 Expression is Not Prognostic","volume":"8","author":"Oguejiofor","year":"2017","journal-title":"Oncotarget"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.87","article-title":"Expression of LRIG1 is Associated With Good Prognosis and Human Papillomavirus Status in Oropharyngeal Cancer","volume":"110","author":"Lindquist","year":"2014","journal-title":"Br J Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/gm453","article-title":"Targeted Next-Generation Sequencing of Head and Neck Squamous Cell Carcinoma Identifies Novel Genetic Alterations in HPV+ and HPV- Tumors","volume":"5","author":"Lechner","year":"2013","journal-title":"Genome Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejca.2016.01.003","article-title":"Targeted Next-Generation Sequencing of Locally Advanced Squamous Cell Carcinomas of the Head and Neck Reveals Druggable Targets for Improving Adjuvant Chemoradiation","volume":"57","author":"Tinhofer","year":"2016","journal-title":"Eur J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15240","article-title":"Targeted Sequencing of Tonsillar and Base of Tongue Cancer and Human Papillomavirus Positive Unknown Primary of the Head and Neck Reveals Prognostic Effects of Mutated FGFR3","volume":"8","author":"Bersani","year":"2017","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12774","article-title":"Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome","volume":"38","author":"Bersani","year":"2018","journal-title":"Anticancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.595","article-title":"Fibroblast Growth Factor Receptor 3 Protein is Overexpressed in Oral and Oropharyngeal Squamous Cell Carcinoma","volume":"5","author":"Koole","year":"2016","journal-title":"Cancer Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz224","article-title":"Pik3ca Mutation in HPV-Associated Opscc Patients Receiving Deintensified Chemoradiation","volume":"112","author":"Beaty","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2018.1491795","article-title":"Future Applications of FGF\/FGFR Inhibitors in Cancer","volume":"18","author":"Ghedini","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2019.02.002","article-title":"PIK3CA in Cancer: The Past 30 Years","volume":"59","author":"Arafeh","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10973","article-title":"In Vitro Antitumor Effects of FGFR and PI3K Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Cell Lines","volume":"18","author":"Holzhauser","year":"2019","journal-title":"Oncol Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3334","article-title":"Multicenter Phase I Study of Erdafitinib (Jnj-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced or Refractory Solid Tumors","volume":"25","author":"Bahleda","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2006.09.001","article-title":"The Influence of Clinical and Demographic Risk Factors on the Establishment of Head and Neck Squamous Cell Carcinoma Cell Lines","volume":"43","author":"White","year":"2007","journal-title":"Oral Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ijporl.2008.12.013","article-title":"Toll-Like Receptros in Tonsillar Epithelial Cells","volume":"73","author":"Lange","year":"2009","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7709","article-title":"Sensitivity of Human Papillomavirus-Positive and -Negative Oropharyngeal Cancer Cell Lines to Ioinizing Irradiation","volume":"44","author":"Holzhauser","year":"2020","journal-title":"Oncol Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207934","article-title":"Sensitivity to Inhibition of DNA Repair by Olaparib in Novel Oropharyngeal Cancer Cell Lines Infected With Human Papillomavirus","volume":"13","author":"Pirotte","year":"2018","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4896","article-title":"Analyses of FGFR3 and PIK3CA Mutations in Neuroblastomas and the Effects of the Corresponding Inhibitors on Neuroblastoma Cell Lines","volume":"55","author":"Kostopoulou","year":"2019","journal-title":"Int J Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.21873\/anticanres.13925","article-title":"Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-Kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines","volume":"40","author":"Holzhauser","year":"2020","journal-title":"Anticancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.549","article-title":"Analysis of Drug Combinations: Current Methodological Landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.04.024","article-title":"A Model for Predicting Clinical Outcome in Patients with Human Papillomavirus-Positive Tonsillar and base of Tongue Cancer","volume":"51","author":"Tertipis","year":"2015","journal-title":"Eur J Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.01.021","article-title":"A Functional Genetic Screen Identifies the Phosphinositide 3-Kinas Pathway as a Determinant of Resistance to Fibroblast Grown Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma","volume":"71","author":"Wang","year":"2017","journal-title":"Eur Urol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.161","article-title":"Ligand-Associated ERBB2\/3 Activation Confers Acquired Resistance to FGFR Inhibition in FGFR3-dependent Cancer Cells","volume":"34","author":"Wang","year":"2015","journal-title":"Oncogene"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0569","article-title":"Parallel RNA Interference Screens Identify EGFR Activation as an Escape Mechanism in FGFR3-mutant Cancer","volume":"3","author":"Herrera-Abreu","year":"2013","journal-title":"Cancer Discovery"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5801","article-title":"Targeting VEGFR and FGFR in Head and Neck Squamous Cell Carcinoma In Vitro","volume":"38","author":"Brands","year":"2017","journal-title":"Oncol Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0509","article-title":"Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC","volume":"75","author":"Singleton","year":"2015","journal-title":"Cancer Res"},{"key":"B51","article-title":"Combined Inhibition of FGFR and mTOR Pathways is Effective in Suppressing Ovarian Cancer","volume":"11","author":"Cai","year":"2019","journal-title":"Am J Transl Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1665","article-title":"First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients With Advanced Solid Tumor Malignancies","volume":"22","author":"Munster","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41389-017-0018-2","article-title":"Novel Therapeutic Strategy for Cervical Cancer Harboring FGFR3-TACC3 Fusions","volume":"7","author":"Tamura","year":"2018","journal-title":"Oncogenesis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3892\/ol.2020.12189","article-title":"Synergistic Antitumor Effect of Dual PI3K and mTOR Inhibitor NVP-BEZ235 in Combination With Cisplatin on Drug-Resistant non-Small Cell Lung Cancer Cell","volume":"20","author":"Zhu","year":"2020","journal-title":"Oncol Lett"},{"key":"B55","article-title":"Preclinical Evaluation of PI3K Inhibitor BYL719 as a Single Agent and its Synergism in Combination With Cisplatin or MEK Inhibitor in Nasopharyngeal Carcinoma (NPC)","volume":"5","author":"Wong","year":"2015","journal-title":"Am J Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2014-5522","article-title":"In Vitro Anticancer Activity of PI3K Alpha Selective Inhibitor BYL719 in Head and Neck Cancer","volume":"35","author":"Keam","year":"2015","journal-title":"Anticancer Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.canlet.2013.09.007","article-title":"Preclinical Evaluation of the mTOR-PI3K Inhibitor BEZ235 in Nasopharyngeal Models","volume":"343","author":"Ma","year":"2014","journal-title":"Cancer Lett"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.640490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T06:44:29Z","timestamp":1620715469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.640490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":57,"alternative-id":["10.3389\/fonc.2021.640490"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.640490","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"article-number":"640490"}}